<?xml version="1.0" encoding="UTF-8"?>
<p>Compounds antagonizing the function of cellular chaperones represent an emergent class of anticancer and antiviral therapeutics (
 <xref rid="R21" ref-type="bibr">
  <italic>21</italic>
 </xref>, 
 <xref rid="R22" ref-type="bibr">
  <italic>22</italic>
 </xref>). Chaperones of the HSP90 family are required when the cell is growing fast and/or producing high levels of proteins, as observed in cancer cells or in virus-infected cells. Seminal studies from the Frydman and Andino laboratories demonstrate a clear, essential role for HSP90 in the production of infectious PV virions (
 <xref rid="R23" ref-type="bibr">
  <italic>23</italic>
 </xref>). However, every step of the virus lifecycle has been suggested as a target for HSP90 when viruses outside of the picornavirus family are considered (
 <xref rid="R22" ref-type="bibr">
  <italic>22</italic>
 </xref>, 
 <xref rid="R24" ref-type="bibr">
  <italic>24</italic>
 </xref>). The benefit of targeting antiviral therapeutics to cellular proteins is that the likelihood for evolution of resistance is minimized (
 <xref rid="R23" ref-type="bibr">
  <italic>23</italic>
 </xref>).
</p>
